Marshall Financial Group, LLC

Position in ABBV — AbbVie Inc.

CIK 1841496 Hunt Valley, MD

Position in ABBV

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$260,195

+$30,091 QoQ

Shares Held

1,034

-2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#3,752

of 4,153 holders

Holding Since

Jun 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Marshall Financial Group, LLC holds $15,627,500 across 8 Drug Manufacturers - General names. ABBV ranks #8 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	35,820	$4,602,870
2	NVS	Novartis AG	17,632	$2,763,287
3	JNJ	Johnson & Johnson	10,123	$2,570,938
4	AMGN	Amgen Inc	6,736	$2,439,240
5	LLY	ELI LILLY & Co	1,613	$1,934,680
6	AZN	Astrazeneca PLC	4,153	$787,491
7	NVO	Novo Nordisk A S	5,607	$268,799
8	ABBV	AbbVie Inc. This page	1,034	$260,195

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$260,195	1,034	-2.3%	Shares	Sole	2026-07-20
2026-03-31	$230,104	1,058	-2.4%	Shares	Sole	2026-04-13
2025-12-31	$247,683	1,084	-10.3%	Shares	Sole	2026-01-09
2025-09-30	$279,700	1,208	-7.7%	Shares	Sole	2025-10-08
2025-06-30	$242,976	1,309	-77.7%	Shares	Sole	2025-07-10
2025-03-31	$1,231,349	5,877	-2.2%	Shares	Sole	2025-04-16
2024-12-31	$1,068,332	6,012	+7.8%	Shares	Sole	2025-01-21
2024-09-30	$1,101,345	5,577	+3.6%	Shares	Sole	2024-10-16
2024-06-30	$923,292	5,383	-48.6%	Shares	Sole	2024-07-19
2024-03-31	$1,905,676	10,465	+5.6%	Shares	Sole	2024-04-19
2023-12-31	$1,535,287	9,907	+580.4%	Shares	Sole	2024-01-10
2023-03-31	$232,042	1,456	-79.1%	Shares	Sole	2023-04-18
2022-12-31	$1,127,068	6,974	+11.9%	Shares	Sole	2023-02-01
2022-09-30	$836,128	6,230	+2.1%	Shares	Sole	2022-10-12
2022-06-30	$934,888	6,104	—	Shares	Sole	2022-07-25
No filing history on record for this holder in this stock.